Industry Segment

Diagnostics

Browse market forecasts, competitive intelligence, demand signals and strategic research across Diagnostics.

Research Coverage

Explore the focus areas

Testing demand is becoming more selective as reimbursement models increasingly link diagnostic use to measurable clinical impact rather than volume. Providers are reducing reliance on routine, repeat testing where outcomes remain unchanged, which is shifting demand toward diagnostics that directly influence treatment decisions. This change is elevating the importance of accuracy and clinical validation, as even small improvements in diagnostic confidence can reduce downstream interventions. At the same time, high-complexity testing continues expanding in areas such as oncology and genetic profiling, where diagnostics play a central role in guiding therapy rather than confirming conditions.

Adoption patterns are diverging across care settings as the value of rapid diagnostics depends heavily on where they are used. Emergency and urgent care environments are increasing use of point-of-care testing because faster results enable immediate decisions that reduce admissions and treatment delays. In contrast, primary care settings are adopting more gradually due to budget limitations, regulatory requirements, and less immediate economic benefit from rapid testing. Diagnostics are also becoming more integrated into chronic disease management, where frequent monitoring supports adherence and early intervention, creating steady demand beyond episodic care.

Patient access is playing a larger role in shaping diagnostic demand as testing expands beyond traditional clinical environments. Retail clinics and pharmacy-based providers are incorporating diagnostics into routine services, making testing more accessible and convenient. This is encouraging earlier and more frequent testing, particularly for preventive and wellness-related use cases. However, adoption depends on the ability to integrate results into clinical workflows, as disconnected systems can limit the practical value of increased access.

Operational factors are continuing to influence how diagnostic services scale, particularly in regions where sample collection and transport infrastructure is limited. Laboratories are focusing on improving turnaround times and expanding collection networks to maintain service reliability. At the same time, advances in testing technology are enabling more flexible deployment models, including decentralized and near-patient testing. These shifts are supporting gradual expansion of diagnostic services into new settings, while maintaining the need for accuracy, compliance, and efficiency.

Latest Reports

449 reports
Chlamydia Infection Diagnostics Market Size, Share, Opportunities, And Trends By Product Type (Diagnostics, Therapeutics), By Test Type (Culture Tests, Nucleic Acid Amplification Test, Direct Fluorescent Antibody Test, Serology Tests, Others), By End-User (Hospitals, Diagnostic Centers, Others), And By Geography - Forecasts From 2024 To 2029
Healthcare/January 2024

Chlamydia Infection Diagnostics Market Size, Share, Opportunities, And Trends By Product Type (Diagnostics, Therapeutics), By Test Type (Culture Tests, Nucleic Acid Amplification Test, Direct Fluorescent Antibody Test, Serology Tests, Others), By End-User (Hospitals, Diagnostic Centers, Others), And By Geography - Forecasts From 2024 To 2029

The chlamydia infection diagnostics market was valued at US$1,211.526 million in 2022. Chlamydia diagnostics are tests and procedures used to identify the chlamydia trachomatis bacteria’s presence in an individual. It is a sexually t...

Indian Prostate Cancer MRI Diagnostic Market Size, Share, Opportunities, And Trends By Technique (T1WI, T2WI, Others), By End-User (Hospitals, Diagnostic Laboratories), By Cancer Type (Adenocarcinoma, Transitional cell carcinoma, Others), And By State - Forecasts From 2023 To 2028
Healthcare/January 2024

Indian Prostate Cancer MRI Diagnostic Market Size, Share, Opportunities, And Trends By Technique (T1WI, T2WI, Others), By End-User (Hospitals, Diagnostic Laboratories), By Cancer Type (Adenocarcinoma, Transitional cell carcinoma, Others), And By State - Forecasts From 2023 To 2028

The India prostate cancer MRI diagnostics market is projected to grow at a CAGR of 11.08% over the forecast period, increasing from INR392.442 million in 2021 to INR818.886 million by 2028. The market is anticipated to grow as a result of...

Germany Flu Diagnostic and Treatment Market Size, Share, Opportunities, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
Healthcare/November 2022

Germany Flu Diagnostic and Treatment Market Size, Share, Opportunities, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The Germany flu diagnostic and treatment market is projected to grow at a CAGR of 14.13% throughout the forecast period to reach US$6,653.487 million in 2027, from US$2,638.271 million in 2020. The market for flu diagnostics and treatment ...

Spain Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
Healthcare/August 2022

Spain Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The Spain flu diagnostic and treatment market is projected to grow at a CAGR of 9.71% throughout the forecast period to reach US$1,432.649 million in 2027, from US$749.058 million in 2020. The flu diagnostic and treatment market in Spain...

France Flu Diagnostics Market - Strategic Insights and Forecasts (2026-2031)
Healthcare/August 2022

France Flu Diagnostics Market - Strategic Insights and Forecasts (2026-2031)

The French flu diagnostic and treatment market comprises a comprehensive ecosystem of clinical screening tools and pharmacological interventions designed to manage seasonal and pandemic influenza. Core product categories include rapid molec...

Brazil Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
Healthcare/August 2022

Brazil Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The Brazil flu diagnostic and treatment market is projected to grow at a CAGR of 15.40% throughout the forecast period to reach US$3,575.032 million in 2027, from US$1,311.902 million in 2020. The growing burden of influenza across Brazi...

United Kingdom Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
Healthcare/August 2022

United Kingdom Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The United Kingdom flu diagnostic and treatment market is projected to grow at a CAGR of 14.98% throughout the forecast period to reach US$4,487.979 million in 2027, from US$1,689.332 million in 2020. The growth of flu diagnostics and tr...

Turkey Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027
Healthcare/August 2022

Turkey Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

The turkey infection control market is projected to grow to a market size of US$160.193 million by 2027, at a CAGR of 6.15%. The market was valued at US$105.519 million in 2020. Increased disposable income to propel the spending on advan...

South Africa Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
Healthcare/August 2022

South Africa Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The South African flu diagnostic and treatment market is projected to grow at a CAGR of 6.31% throughout the forecast period to reach a market value of US$283.238 million by 2027. The market was valued at US$184.504 million in 2020. The...

Qatar Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
Healthcare/August 2022

Qatar Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The Qatar flu diagnostic and treatment market is projected to grow at a CAGR of 6.82% throughout the forecast period and reach a market value of US$45.714 million by 2027. The market is valued at US$28.798 million in 2020. The flu diagn...

UAE Flu Diagnostic and Treatment Market Size, Share, Opportunities, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
Healthcare/August 2022

UAE Flu Diagnostic and Treatment Market Size, Share, Opportunities, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The UAE flu diagnostic and treatment market is projected to grow at a CAGR of 8.76% throughout the forecast period to reach a market size of US$185.051 million by 2027. The market was valued at US$102.775 million in 2020. Seasonal flu outb...

U.S. Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
Healthcare/August 2022

U.S. Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The U.S. flu diagnostic and treatment market is projected to grow at a CAGR of 14.01% throughout the forecast period to reach a market value of US$32,324.419 million by 2027. The market was valued at US$12,906.707 million in 2020. Accordin...

Related Intelligence Hubs

Explore interconnected markets and cross-industry research.